9/27/2023 0 Comments Microsoft surface 1724![]() ![]() ![]() Preliminary fourth quarter 2022 UPNEEQ net product sales were $12.1 million refinement to revenue methodologies results in final fourth quarter 2022 UPNEEQ net product sales of $9.8 million, an increase of $6.7 million, or 216%, over 2021 $2.3 million now recognized in first quarter 2023 -īRIDGEWATER, N.J., Ma(GLOBE NEWSWIRE) - RVL Pharmaceuticals plc (Nasdaq: RVLP) ("RVL" or the "Company"), a specialty pharmaceutical company, today announced financial results and business highlights for the three months and full year ended December 31, 2022. ![]() Full year 2022 UPNEEQ net product sales of $34.2 million, an increase of $26.7 million, or 356%, over 2021. Full year 2022 total revenues of $49.7 million, an increase of $32.2 million, or 184%, over 2021. RVLP records exceptional year-over-year growth with UPNEEQ ® launch into the medical aesthetics market. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |